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Abstract: 
The Republic of Croatia, with gross domestic product per capita of 11,554 US $ in the 
year 2008, is economically less developed western country. The goal of this investigation is to 
prove that a well organised primary percutaneous coronary intervention (PCI) network in 
an economically less developed country equalizes the prospects of all patients with acute ST elevation 
myocardial infarction (STEMI) at the level comparable to economically more 
developed countries. The authors prospectively investigated 1190 acute STEMI patients 
treated with primary PCI in eight centers across Croatia (677 non-transferred, 513 
transferred). Postprocedural TIMI flow, in-hospital mortality and major adverse 
cardiovascular events (MACE) (mortality, pectoral angina, restenosis, reinfarction, coronary 
artery by-pass graft and cerebrovascular accident rate) in the six-month follow-up were compared 
between non-transferred and transferred subgroups in general, as well as in subgroups of older 
patients, female gender and those with cardiogenic shock. In all investigated patients the average door-
to-balloon time was 108 minutes and total ischemic time 265 minutes, postprocedural TIMI 3 flow 
was established in 87.1% of them, while in-hospital mortality was 4.4%. No statistically significant 
difference in results of treatment was found between transferred and non-transferred patients in 
general, as well as in subgroups of older than 75 years, female gender and those with cardiogenic 
shock. In conclusion, Croatian Primary PCI Network ensures results of treatment of acute STEMI 
comparable to those of randomised studies and registries of economically more developed countries.  
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INTRODUCTION 
In the year 2002, 5,525 Croatians suffered from acute myocardial infarction, and 
approximately 4,000 had STEMI. Out of them 54% were treated in the county institutions with less 
than 100 acute myocardial infarctions a year and without interventional capabilities. Among these 
patients 62% were men, 39% were capable of working actively (22% women and 49% men), and more 
were affected by arterial hypertension and diabetes compared to other European countries. Such a high 
percentage of STEMI could be explained by underdiagnosis and underreporting of NSTEMI in that 
time.1-2 In the year 2007, 6,420 Croatians were hospitalised because of acute myocardial infarction, but 
with decreasing tendency of cardiovascular mortality in general.3  
Having recognised the above said problems related with treating acute STEMI in 
Croatia, and knowing the world trends and recommendations, in the middle of 2005 Croatian 
Cardiac Society introduced Croatian Primary PCI Network into the health care system of the 
Republic of Croatia. The main goal was to achieve equal quality treatment of acute STEMI in all 
parts of Croatia. Currently, 8 high-volume PCI centers all over Croatia are included in this network 
covering around 75% of population (Figure 1).4 
The main goals of this investigation are:1.) To evaluate treatment results of patients with acute 
STEMI treated with primary PCI in Croatian Primary PCI Network and to compare these results with 
published randomised studies and registries data; 2.) To prove equality of treatment results in all 
Croatian Primary PCI Network patients even in those at higher risk (older patients, female gender, 
patients in cardiogenic shock).  The main hypothesis is that a well organised primary PCI network, 
even in an economically less developed country, equalizes the prospects of all STEMI patients in all 
parts of the country at a level comparable to that in economically more developed countries. 
 
METHODS 
This investigation prospectively studies 1190 consecutive acute STEMI patients treated 
between September 1, 2005 and March 1, 2007 with primary PCI in eight PCI centres in all parts of 
Croatia (four with and four without on-site cardiac surgery) included in the Croatian Primary PCI 
Network. In 677 investigated patients acute STEMI was diagnosed in one of the centers with on-site 
PCI laboratory (cath-lab), where primary PCI was performed (non-transferred patients). In the 
remaining 513 patients acute STEMI was diagnosed in the hospitals without on-site cath-lab, so they 
were urgently transferred with ambulance to already quoted PCI centers for primary PCI (transferred 
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patients). The diagnosis of STEMI was established and primary PCI performed using the actual 
criteria of the European Cardiac Society.5 In brief, the patients with an episode of chest discomfort 
within the last 12 hours and ST-elevation in the ECG in at least two consecutive leads were included. 
Immediately after diagnosis, patients waiting for transfer (transferred) or primary PCI (non-
transferred) patients received the loading dose of 300 mg salicylic acid, 600 mg clopidogrel, and 
intraprocedurally 70-100 IE/kg of unfractionated heparin, and, according to judgment of interventional 
cardiologist, a GPIIb/IIIa inhibitor. 
After primary PCI the patients were hospitalized on average 2 to 3 days in coronary 
care units in PCI centers with continuous monitoring and treatment. Afterwards  they finished 
their hospital treatment in cardiac departments of those hospitals (non-transferred patients), or 
they were transferred back to their county hospitals (transferred patients). During their first 
hospital stay, general information (name, age, gender) and information on the time of the first 
symptoms, time of arrival in the first hospital and/or PCI center, time of the first balloon 
insufflation during primary PCI, affected myocardial wall and coronary artery, postprocedural 
flow, as well as eventually cardiogenic shock and lethal outcome were collected. Six months 
after discharge, data about major adverse cardiovascular events (MACE) (pectoral angina, 
restenosis, reinfarction, mortality, coronary artery by-pass graft surgery and cerebrovascular accident 
rate) were collected for investigated patients during their examination, by checking medical 
documentation or by telephone contact with patients, patients' family members or home 
physicians. Including the follow-up, this investigation covers the period between September 1, 2005 
and August 3, 2007. 
Cardiogenic shock was defined as a clinical state of hypoperfusion characterised by 
systolic blood pressure <90 mmHg and/or capillary wedge pressure >20 mmHg and/or cardiac 
index <1.80 l/min m2.5 Total ischemic time or symptom onset-to-balloon time was 
calculated as the time between the first symptoms and balloon insufflation during primary 
PCI, door-to-balloon time as the time between arrival in the first hospital (with or without on-site 
cath-lab) and balloon insufflation during primary PCI, symptom onset-to-door time as the 
time between the first symptoms and arrival in the first hospital (with or without on-site cathlab). 
Postprocedural flow was classified according to the Thrombolysis in Myocardial 
Infarction (TIMI) grading system at the scale of 0-3.6 
Nominal (categorical) variables were analysed using Pearson Chi-Square and Fisher's 
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Exact Test, and quantitative variables by Mann-Whitney Test. Differences between 
subgroups with elimination of influence of other variables were analysed using multivariate 
log-linear analysis. The value of p<0.05 was considered significant for all used tests. The 
statistical analysis was performed by using Statistica 6.0 program. 
The investigation was performed in accordance with the ethical standards laid down in 
the Declaration of Helsinki and was approved by the appropriate institutional review 
committees. 
 
RESULTS 
 The descriptive statistic data and times to reperfusion of all investigated patients, 
transferred and non-transferred, are shown in Table 1 and the results of their treatment in 
Table 2. There are no significant differences between transferred and non-transferred patients 
in the investigated descriptive parameters. Also, a higher percent of cardiogenic shock among 
non- transferred patients was insignificant. The average distance of transfer in the subgroup of 
transferred patients was 72 kilometers. The latter group of patients has longer door-to-balloon 
and symptom onset-to-balloon times, which can be expected because transfer time is included 
in the two times to reperfusion. In Croatian Primary PCI Network during the investigated 
period 37% of all investigated patients received primary PCI within recommended 90 minutes 
after arrival in the first hospital. Among non-transferred patients this percentage was 47%, 
and among transferred 25%. Transferred patients in this investigation have tendency of better 
treatment results compared to non-transferred, but without statistical significance at the 
multivariate level. During primary PCI 93% of patients received stents. Follow-up data rate was 89%.  
The descriptive statistical data and times to reperfusion of subgroups of patients older than 75 
year, female patients in cardiogenic shock are shown in Table 3, and the results of their treatment in 
Table 4. In comparison with all investigated patients, those older than 75 years have higher percentage 
of patients with cardiogenic shock, especially non- transferred, and their times-to-reperfusion are 
longer. There are no significant differences in the results of treatment between transferred and 
nontransferred older patients, but the results for both subgroups are worse than those for all 
investigated patients. In comparison with the results for all investigated patients, female patients are 
older, with all times-to-reperfusion longer, and somewhat worse treatment results. Patients with 
cardiogenic shock are on average older with more frequently culprit lesion at the left main level than 
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all investigated patients. Results of their treatment and their prognosis are more serious than those of 
patients without this complication. 
Authors found no statistically significant differences in investigated results of treatment 
between subgroups of patients treated in PCI centers with and without cardiosurgical back-up. Also, 
among door-to-balloon subgroups (<90, 90-180, and >180 minutes) none of results differences was 
statistically significant. Among onset-to-balloon time subgroups (<90, 90-180, 180-360, and >360 
minutes) a statistically significant difference on multivariate level was found only for in-hospital 
mortality in the subgroup of patients with longest onset-to-balloon time (3.5 vs. 4.5 vs.2.6 vs. 5.7%, 
p=0.04). 
 
DISCUSSION 
Average age, gender distribution, affected myocardial wall, as well as coronary 
arteries in transferred and non-transferred patients in this investigation correspond to the 
results of other such investigations at hospital, regional or national level.7-12 The percentage of patients 
with cardiogenic shock in the literature that investigated primary PCI in STEMI is between 2% in 
PRAGUE-2 study9 and 7-12% in other studies10,11,13 compared to our 6.7% . Somewhat higher 
percentage of this complication among non-transferred patients in this study is insignificant, but could 
be reason for better results of transferred patients. The average transport distance of 72 kilometers also 
corresponds to such distances in DANAMI7 (3-150 kilometers) and PRAGUE-2 study (5-120 
kilometers).9 
Vienna STEMI Registry Group12, on smaller area in comparison with the Croatian 
Primary PCI Network, found shorter door-to-balloon time, but because of relatively long 
symptom onset-to-door time total ischemic times are similar. All times to reperfusion in 
DANAMI study7, as well as in Emilia-Romagna ST-segment elevation acute myocardial 
infarction network11 are shorter than in this study. On the other hand, the results of these times 
in investigations outside Europe are worse than in this and in other European studies (for 
example, average door-to-balloon time of 142 minutes in Canadian transferred patients or 
128 minutes in transferred patients in the USA).14,15  In comparison with ACTION Registry16 
from the United States, the percentage of transferred patients treated with primary PCI 
within 90 minutes after arrival in the first hospital is higher in this study (12 vs. 25%), but not 
in non-transferred patients (80 vs. 47%). Investigating the same percentages, Italian 
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investigators on regional network level report better results (32% for transferred and 70% for 
non-transferred). After these results, the leaders of the Croatian Primary PCI Network started 
with actions for improvement of door-to-balloon time, especially in non-transferred patients.17 
Percents of optimal postprocedural TIMI flow in this study, and other similar studies8,9,18  are 
positioned between 82% reported in DANAMI7 and 95% by German authors in 2007.13 Italian11 and 
German13  groups also found better postprocedural TIMI flow in transferred patients. Early mortality 
rates reported in similar studies10,19 are between 2.1 and 8.1% and, among other things, depend on 
definition (in-hospital or 30-day mortality). Reported mortality rates in six months to one year are 
mostly between 7 and 10%, and also depend on the duration of the follow-up.7-9,11,18 Problem with 
definition of MACE (types of events included, duration of follow-up) was found in their comparison 
between studies.7-9,11-13 Nevertheless, results for mortality and MACE revealed in the Croatian Primary 
PCI Network investigation and quoted in Table 2 are mostly within the frameworks of such results 
reported in other primary PCI networks established at city, regional or national level in economically 
more developed countries compared to Croatia (Table 5). 
Relatively higher percentage of female gender among older patients, higher percentage 
of complex coronary lesions and complications, as well as longer times to reperfusion are 
reported in the literature.5,12,20 Lower percentage of optimal postprocedural TIMI flow, 
and higher mortality rate among older patients are also known from the literature.19,21 All these 
tendencies are found in our investigation too. The absence of significant differences in the 
results of treatment between transferred and non-transferred older patients found here proves 
that the Croatian Primary PCI Network ensures equal treatment for this hazardous subgroup of 
patients in all parts of the country. 
There are reports22,23 that find no significant difference between genders in the results 
of primary PCI in acute STEMI or PCI in general. On the other hand, data from the Austrian 
acute PCI registry12 revealed higher age, higher percentage of cardiogenic shock, as well as 
higher in-hospital mortality in female gender, while another study24 proved worse prognosis 
of female patients only during follow-up. The latter results (higher age, more cardiogenic 
shock, and even longer times to reperfusion) are found also in this investigation, as well as 
less benefit of primary PCI in female compared to male patients. Nevertheless, the authors 
again find no significant difference between transferred and non-transferred subgroups of 
female patients. 
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Older age, female gender, three-vessel disease and disease of proximal parts of 
coronary arteries, infarction of anterior myocardial wall, as well as longer times to 
reperfusion, are independent risk factors for cardiogenic shock in acute STEMI.25,26 In this 
investigation, patients in cardiogenic shock are also older with more left-main culprit lesions 
and tendency of more infarctions of the anterior wall. The introduction of primary PCI in the 
treatment of acute STEMI complicated with cardiogenic shock reduced mortality from over 
80% to 40-50%.17,26,27 Postprocedural TIMI flow less than 3 is an independent factor for 
occurrence and prognosis of cardiogenic shock.25,26 Percentage of postprocedural TIMI flow 3 
and in-hospital mortality rate found in this investigation (Table 4) are similar to results in 
quoted studies. The absence of significant differences in the results between transferred and 
nontransferred subgroups of patients in cardiogenic shock again proved equal treatment for this 
hazardous subgroup of patients in all parts of Croatia. 
 
ACKNOWLEDGEMENT 
Contributing authors: 
Sestre milosrdnice University Hospital (UH), Zagreb: Hrvoje Pintaric, Kresimir Stambuk, 
Sime Manola, Marin Pavlov, Sime Mihatov  
Clinical Hospital Center Zagreb, Zagreb: Aleksander Ernst, Eduard Margetic, Ivan Skorak, 
Kreso Putarek, Bruno Skoric, Danijel Lovric  
Dubrava UH, Zagreb: Miomir Veskovic, Nikola Todorovic, Josica Sikic, Drazen Sebecic, 
Sveti Duh General Hospital (GH), Zagreb: Edvard Galic, Ilko Vuksanovic  
Clinical Hospital Center Rijeka, Rijeka: Rajko Miskulin, Djuro Marinovic, David Gobic, 
Vjekoslav Tomulic  
Clinical Hospital Center Split, Split: Branimir Markovic, Josip Lukenda  
Osijek UH, Osijek: Damir Kozmar, Zorin Makarovic, Damir Kirner  
Magdalena Special hospital for Cardiovascular surgery and Cardiology, Krapinske Toplice: 
Mihajlo Sesto, Robert Bernat, Nikola Milicic, Hrvoje Stipic, Tomislav Sipic  
Cakovec GH, Cakovec: Rudolf Hranilovic  
Bjelovar GH, Bjelovar: Mario Ivanusa  
Zabok GH, Zabok: Stjepan Rogan  
Varazdin GH, Varazdin: Dubravko Trsinski  
 10
Conflict of interests: none declared. 
 11
REFERENCES  
 
1. Ivanuša M. Fibrinolytic therapy: what size to fit all? Circulation 2003;108:E170. 
2. Kotseva K, Wood D, De Backer G et al. EUROASPIRE I and II Group; European 
Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of 
coronary prevention guidelines: A comparison of EUROASPIRE I and II in nine 
countries. Lancet 2001;357:995-1001. 
3. Ministry of Health and Social Welfare of the Republic of Croatia. Croatian health 
indicators. Croatian National Institute of Public Health. Zagreb 2008. 
4. Nikolic Heitzler V, Babic Z, Milicic D, Bergovec M, Raguz M, Mirat J, Strozzi M, 
Plazonic Z, Giunio L, Steiner D. Croatian Primary PCI Network-two years results. 
Acute Cardiac Care 2008;3:95. 
5. Sigmund Silber, Per Albertsson, Francisco F. Avilés, Paolo G. Camici, Antonio 
Colombo, Christian Hamm, Erik Jørgensen, Jean Marco, Jan-Erik Nordrehaug, Witold 
Ruzyllo, Philip Urban, Gregg W. Stone, William Wijns. Giudelines for percutaneous 
coronary interventions. The Task Force for Percutaneous Coronary Interventions of 
the European Society of Cardiology. Eur Heart J 2005;26:804-847. 
6. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I 
findings. New Engl J Med 1985;312:932-936. 
7. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, 
Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt 
T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS; DANAMI-2 
Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute 
myocardial infarction. N Engl J Med 2003;349:733-742. 
8. Widimský P, Groch L, Zelízko M, Aschermann M, Bednár F, Suryapranata H. 
Multicenter randomized trial comparing transport to primary angioplasty vs. 
immediate thrombolysis vs combined strategy for patients with acute myocardial 
infarction presenting to a community hospital without a catheterization laboratory. The 
PRAGUE Study. Eur Heart J 2000;21:823-831. 
9. Widimský P, Budesínský T, Vorác D, Groch L, Zelízko M, Aschermann M, Branny 
M, St'ásek J, Formánek P; 'PRAGUE' Study Group Investigators. Long distance 
 12
transport for primary angioplasty vs. immediate thrombolysis in acute myocardial 
infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur 
Heart J 2003;24:94-104. 
10. Kalla K, Christ G, Karnik R, Malzer R, Norman G, Prachar H, Schreiber W, Unger G, 
Glogar HD, Kaff A, Laggner AN, Maurer G, Mlczoch J, Slany J, Weber HS, Huber K; 
Vienna STEMI Registry Group. Implementation of guidelines improves the standard 
of care: the Vienna registry on reperfusion strategies in ST-elevation myocardial 
infarction (Vienna STEMI registry). Circulation 2006;113:2398-2405. 
11. Manari A, Ortolani P, Guastaroba P, Casella G, Vignali L, Varani E, Piovaccari G, 
Guiducci V, Percoco G, Tondi S, Passerini F, Santarelli A, Marzocchi A. Clinical 
impact of an inter-hospital transfer strategy in patients with ST-elevation myocardial 
infarction undergoing primary angioplasty: the Emilia-Romagna ST-segment elevation 
acute myocardial infarction network. Eur Heart J 2008;29:1834-1842. 
12. Suessenbacher A, Doerler J, Alber H, Aichinger J, Altenberger J, Benzer W, Christ G, 
Globits S, Huber K, Karnik R, Norman G, Siostrzonek P, Zenker G, Pachinger O, 
Weidinger F. Gender-related outcome following percutaneous coronary intervention 
for ST-elevation myocardial infarction: data from the Austrian acute PCI registry. 
EuroIntervention 2008;4:271-276. 
13. Schneider H, Ince H, Rehders T, Karber T, Weber F, Kische S, Chatterjee T, Nienaber 
CA for Drip&Ship Netzwerk (District of Rostock Infarct Project & Shipping Patients). 
Treatment of acute ST-elevation myocardial infarction in a regional network (Drip & 
Ship Network Rostock). Herz 2007;32:635-640. 
14. Jollis JG, Roettig ML, Aluko AO, Anstrom KJ, Applegate RJ, Babb JD, Berger PB, 
Bohle DJ, Fletcher SM, Garvey JL, Hathaway WR, Hoekstra JW, Kelly RV, Maddox 
WT Jr, Shiber JR, Valeri FS, Watling BA, Wilson BH, Granger CB; Reperfusion of 
Acute Myocardial Infarction in North Carolina Emergency Departments (RACE) 
Investigators. Implemetation of statewide system for coronary reperfusion for STsegment 
elevation myocatrdial infarction. JAMA 2007;299:2371-2380. 
15. Huynh T, O'Loughlin J, Joseph L, Schampaert E, Rinfret S, Afilalo M, Kouz S, Cantin 
B, Nguyen M, Eisenberg MJ; AMI-QUEBEC Study Investigators. Delays to 
reperfusion therapy in acute ST-segment elevation myocardial infarction: results from 
 13
the AMI-QUEBEC Study. CMAJ 2006;175:1527-32. 
16. Le May MR, So DY, Dionne R, Glover CA, Froeschl MP, Wells GA, Davies RF, 
Sherrard HL, Maloney J, Marquis JF, O'Brien ER, Trickett J, Poirier P, Ryan SC, Ha 
A, Joseph PG, Labinaz M. A citywide protocol for primary PCI in ST-segment 
elevation myocardial infarction. N Engl J Med 2008;358:231-240. 
17. Babić Z. Specifity of Croatian primary PCI network – the results which induce 
changes. 3rd Croatian meeting on cardiovascular interventions. Zagreb, 2009. 
18. Tadel-Kocjančić S, Zorman S, Jazbec A, Gorjup V, Zorman D, Noč M. Effectivnes of 
primary percutaneous coronary intervention for acute ST-elevation myocardial 
infarction from a 5-year single center experience. Am J Cardiol 2008;101:162-168. 
19. Gross BW, Dauterman KW, Moran MG, Kotler TS, Schnugg SJ, Rostykus PS, Ross 
AM, Weaver WD. An approuch to shorten time to infarct artery patency in patients 
with ST-segment elevation myocardial infarction. Am J Cardiol 2007;99:1360-1363. 
20. Shah P, Najafi AH, Panza JA, Cooper HA. Outcomes and quality of life in patients> 
or=85 years of age with ST-elevation myocardial infarction.Am J Cardiol 
2009;103:170-174. 
21. Merchant FM, Weiner RB, Rao SR, Lawrence R, Healy JL, Pomerantsev E, 
Rosenfield K, Jang IK. In-hospital outcomes of emergent and elective percutaneous 
coronary intervention in octogenarians. Coron Artery Dis 2009;20:118-123. 
22. Holmvang L, Mickley H. Gender differences following percutaneous coronary 
intervention. Ther Adv Cardiovasc Dis 2008;2:109-113. 
23. Jankowski P, Kawecka-Jaszcz K, Czarnecka D, Bryniarski L, Brzozowska-Kiszka M, 
Kieć-Wilk B, Dymek G, Kopacz E, Królikowski T, Dudek D. Gender does not 
influence event-free survival in patients with ischemic heart disease undergoing non 
emergency coronary angiography. A single centre analysis. Kardiol Pol 2007;65:475- 
484. 
24. Liu Y, Wang LF, Yang XF, Ge YG, Wang HG, Xu L, Li WM, Ni ZH, Xia K, Chi YH, 
Li Q, Zhang DP, Wu XQ, Sun H, Guo ZS. Gender differences in efficacy of primary 
percutaneous coronary intervention in patients with ST-elevation myocardial 
infarction. Chin Med J (Engl) 2008;121:2374-2378. 
25. Zeymer U, Vogt A, Zahn R, Weber MA, Tebbe U, Gottwik M, Bonzel T, Senges J, 
 14
Neuhaus KL; Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte 
(ALKK). Predictors of in-hospital mortality in 1333 patients with acute myocardial 
infarction complicated by cardiogenic shock treated with primary percutaneous 
coronary intervention (PCI); Results of the primary PCI registry of the 
Arbeitgemainschaft Leitende Kardiologische Krankenhausarzte. Eur Heart J 
2004;25:322-328. 
26. Valente S, Lazzeri C, Chiostri M, Sori A, Giglioli C, Salvadori C, Gensini GF. Time 
of onset and outcome of cardiogenic shock in acute coronary syndromes. J Cardiovasc 
Med (Hagerstown) 2008;9:1235-1240. 
27. Vis MM, Sjauw KD, van der Schaaf RJ, Koch KT, Baan J Jr, Tijssen JG, Piek JJ, de 
Winter RJ, Henriques JP. Prognostic value of admission hemoglobin levels in STsegment 
elevation myocardial infarction patients presenting with cardiogenic shock. 
Am J Cardiol 2007;99:1201-1202. 
28. World Development Indicators database. World Bank, revised 10 September 2008 
http://siteresources.worldbank.org/DATASTATISTICS/Resources/GDP.pdf 
 15
Figure 1. Croatian Primary Percutaneous Coronary Intervention Network 
 
Map of Croatia with PCI centres and 150 km circles of their jurisdiction in acute STEMI  
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Table 1 Descriptive statistic data and times to reperfusion in Croatian Primary PCI Network 
 
Variable All pts. Transferred pts. Non-transferred pts. p 
Age (median, range) 60 y (24-95) 59 y (29-95) 60 y (24-92) 0.08**
Gender (M/F)  73.3%/26,7% 75.7%/24.5% 71.7%/28.3% 0.15*
Myocardial wall (anterior/inferior) 42.6%/57.4% 39.8%/60.2% 44.8%/55.2% 0.12*
Coronary artery  
(LAD/Cx/RCA/LM/by-pass) 
41.7%/13.8%/43.4% 
/0.7%/0.5% 
40.6%/15.6%/42.7% 
/0.4%/0.7% 
42.5%/12.3%/44.0% 
/1.0%/0.2% 0.27*
Cardiogenic shock  6.7% 5.5% 7.6% 0.19*
Symptom onset-to-door (median, range) 130 min. (15-1365) 135 min. (15-1230) 130 min. (15-1365) 0.45**
Door-to-balloon (median, range) 108 min. (10-540) 123 min. (35-540) 96 min. (10-465) <0.01**
Symptom onset -to-balloon (median, range) 265 min. (45-702) 298 min. (84-702) 255 min. (45-695) <0.01**
 
LAD – left anterior descending coronary artery 
ACx – circumflex coronary artery 
RCA – right coronary artery 
LM – left main 
Symptom onset-to-door – time between first symptoms and arrival in the first hospital (with or 
without on-site cath-lab)  
Door-to-balloon – time between arrival in the first hospital (with or without on-site cath-lab) and 
balloon insufflation during primary PCI  
Symptom onset-to-balloon– time between first symptoms and balloon insufflation during primary PCI 
*    χ2 test (transferred vs. non-transferred pts.) 
** Mann-Whitney U-test (transferred vs. non-transferred pts.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 17
Table 2 Results of treatment in Croatian Primary PCI Network 
 
Variable All pts. Transferred pts. Non-transferred pts. p* p** 
Postprocedural TIMI 3 flow 87.1% 89.9% 85.2% 0.03 0.05 
Mortality (in-hospital) 4.4% 2.9% 5.4% 0.04 0.20 
Mortality  (6 month follow-up) 1.2% 0.5% 1.7% 0.24 0.82 
Pectoral angina  (6 month follow-up) 12.1% 11.4% 12.6% 0.70 0.13 
MACE (other) (6 month follow-up) 6.4% 5.8% 7.1% 0.59 0.08 
 
MACE (other) - major adverse cardiovascular events (restenosis, reinfarction, coronary artery by-
pass graft and cerebrovascular accident) 
 *    χ2 test (transferred vs. non-transferred pts.) 
      ** multivariate log-linear analysis (transferred vs. non-transferred pts.) 
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Table 3 Descriptive statistic data and times to reperfusion in subgroups of patients  
 
>75 years Female Cardiogenic shock Variable 
T N-T p T N-T p T N-T p 
Age (median, range) - - - 66(29-92) 
years 
67(24-89) 
years 
0.07 
* 
65 (52-81) 
years 
70 (40-89) 
years 
0.25
** 
Gender (M/F) 66.0% 
/34.0% 
53.0% 
/47.0% 
<0.01 
* 
- - - 75.0% 
/25.0% 
66.7% 
/33.3% 
0.67
* 
Myocardial wall 
(anterior/inferior) 
37.2% 
/62.8% 
43.6% 
/56.4% 
0.05 
* 
35.5% 
/64.5% 
45.4% 
/54.6% 
0.14 
* 
50.0% 
/50.0% 
40.0% 
/60.0% 
0.60
* 
Coronary artery 
(LAD/Cx/RCA/ 
LM/by-pass) 
37.3%/7.7%
/51.0%/2.0% 
/2.0% 
45.1%/11.3% 
/38.0%/ 
5.6%/0 
0.37 
* 
38.2%/15.2
%/45.7% 
/0.9%/0 
41.7%/10.6 
%/45.9% 
/1.2%/0.6% 
0.47 
* 
45.8%/16.7
%/33.3% 
/4.2%/0 
27.5%/12.5 
%/47.5% 
/12.5%/0 
0.32
* 
Cardiogenic shock 15.9% 22.6% 0.40 
* 
5.8% 8.9% 0.48 
* 
- - - 
Symptom onset-to 
-door (median, range) 
171 
(30-1230) 
min. 
155 
(15-1080)  
min. 
0.27 
** 
171 
(20-1230) 
min. 
150 
(30-1080) 
min. 
0.71 
** 
120 
(45-780) 
min. 
180 
(25-1080) 
min. 
0.07
** 
Door-to-balloon (median, 
range) 
162  
(23-540) 
 min. 
110  
(10-330)  
min. 
0.02 
** 
130 
(28-501) 
min. 
100 
(10-355)  
min. 
<0.01 
** 
125 
(40-240) 
min. 
95 
(35-285)  
min. 
0.18
** 
Symptom onset -to-
balloon(median, range) 
348  
(120-650) 
min. 
283  
(45-570)  
min. 
< 0.01
** 
318 
(84-690) 
min. 
270 
(60-660)  
min. 
<0.01 
** 
230 
(145-650) 
min. 
255 
(105-510) 
min. 
0.77
** 
 
LAD – left anterior descending coronary artery 
ACx – circumflex coronary artery 
RCA – right coronary artery 
LM – left main 
Symptom onset-to-door – time between first symptoms and arrival in the first hospital (with or 
without on-site cath-lab)  
Door-to-balloon – time between arrival in the first hospital (with or without on-site cath-lab) and 
balloon insufflation during primary PCI  
Symptom onset-to-balloon– time between first symptoms and balloon insufflation during primary PCI 
*    χ2 test 
** Mann-Whitney U-test 
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Table 4 Results of treatment in subgroups of patients 
>75 years Female Cardiogenic shock Variable 
T NT p* p** T NT p* p** T NT p*  
Postprocedural 
TIMI 3 flow  
81.3 % 73.6 % 0.33 0.26 84.5 81.1 0.58 0.97 38.1 47.4 0.68  
Mortality 
(in-hospital)  
9.4 % 15.4 % 0.32 0.74 2.6 4.9 0.51 0.49 45.5 52.4 0.79  
Mortality 
(6 month follow-up)  
0 % 5.0 % 0.24 0.69 2.0 4.9 0.65 0.74 0 0 -  
Pectoral angina 
(6 month follow-up)  
16.0 % 13.6 % 0.75 0.54 19.2 11.7 0.38 0.84 0 3.5 0.66  
MACE (other) 
(6 month follow-up)  
3.3 % 3.6 % 0.96 - 7.4 9.1 0.98 0.28 6.3 3.7 0.61  
 
MACE (other) - major adverse cardiovascular events (restenosis, reinfarction, coronary artery by-
pass graft and cerebrovascular accident) 
 *    χ2 test 
      ** multivariate log-linear analysis 
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Table 5 Gross domestic product per capita – list of countries (year 2008) 28 
 
COUNTRY GROSS DOMESTIC PRODUCT 
PER CAPITA (US $) 
RANK IN 
WORLD 
DENMARK 56427 6 
UNITED STATES OF AMERICA 45790 10 
AUSTRIA 45343 11 
FRANCE 41523 14 
CANADA 40222 15 
GERMANY 40079 16 
ITALY 35494 18 
SLOVENIA 22523 26 
CZECH REPUBLIC 16271 30 
CROATIA 11554 38 
 
 
 
